@kareem_carr I heard this in grad school, but slightly different. It was about a surgeon who was using a new technique and decided to use the new way on half of his patients and the old way on the other half. Another was the one who stated he was dooming half his patients
@kareem_carr And obviously.... that's totally unbiased
@kareem_carr Well with heterogenous treatment effects... maybe both halves but for opposite reasons? 😅
@kareem_carr Hope that young student grew up to be Reviewer 2.
@kareem_carr Poke @temptoetiam je pense que c'est ta came
@kareem_carr In pharma, most drugs are reviewed against a control of nothing. But when the disease is life threatening, the control has to be the best available treatment. So for drugs such as oncology, the bar is set higher since you have to beat the control that actually does something.
@kareem_carr Not a million miles from something Archie Cochrane did IRL. Compared early Coronary Care Units to home care, found home care was better... but pretended vice versa when first presenting findings to cardiologists. See pp12-13 of this by @bengoldacre en.testingtreatments.org/wp-content/upl…